Advances In Pharmacoepidemiology And Drug Safety

Figure 1: Core goals and multidimensional scope of pharmacoepidemiology.

Goals And Concept Of Pharmacoepidemiology:

Pharmacoepidemiology is described as the investigation of drug use and effects in large populations by using epidemiological methodologies to pharmacological research.⁽¹⁾

Table 1: Pharmacoepidemiologic Goals & Their Public Health Impact

Data Sources For Pharmacoepidemiology

Pharmacoepidemiologic studies use a Various kinds of data sources, such as

1) Electronic Health Records (EHR):

EHR are digitalized patient records that include a wealth of clinical data, such as diagnoses, prescription drugs, test results, and treatment histories. Pharmacoepidemiology makes extensive use of EHRs for Studies on the efficacy of drugs,identification of adverse drug reactions (ADRs), Analysis of population health.⁽³⁾ 

2) Insurance claims databases:

These can be used to find trends in drug use and adverse occurrences and include data on medical claims. These datasets are very helpful for large-scale research on drug use, analysis of cost-effectiveness, long-term safety surveillance. ⁽⁴⁾

3) Patient Registries:

Patient registries are organized systems that collect regular data on individuals with specific Patient registries are structured systems that collect continuous data on individuals with particular illnesses or exposures throughout time. They are particularly useful for rare disease research, long-term safety monitoring, and post-marketing surveillance. ⁽⁵⁾

4) Mobile and Digital Health:

According to recent research, data from social media platforms like Facebook and Twitter can be helpful for analyzing drug safety. Health apps for mobile devices, Wearable technology, Social media networks. These data sources allow for real-time monitoring of health outcomes and drug adherence.⁽³⁾

5) Big Data Analysis:

Big data analytics makes it possible to use huge healthcare utilization databases for long-term follow-up, subgroup analysis, and the investigation of uncommon adverse events. ⁽⁵⁾

6) Prescription Databases:

These types of databases can be used to find patterns of medication use and possible drug interactions. They usually include comprehensive information about medications prescribed to patients, including the medicine name, dose, the duration of the prescription, and the prescribing healthcare professional.⁽⁶⁾

7) Pharmacy Dispensing Databases:

These give information regarding medication adherence and indicate that the patient has received the drug, but they do not guarantee that the medications have been taken. As a result, it is an imprecise measure of drug exposure in an outpatient. ⁽⁷⁾

8) Economic assessment:

This assesses the costs of medical treatment, including preparation, administration, drug monitoring, managing adverse drug reactions (ADRs) (including duration of stay and monitoring tests conducted), and the financial implications of a drug's advantages.⁽⁸⁾

9) National Health Surveys:

 These are extensive surveys that gather data on people's health, usage of healthcare, and use of medications within a population.⁽⁹⁾

10) Pharmacovigilance Databases:

These include data on suspected adverse drug reactions (ADRs), suspected medications, and patient outcomes that are gathered from a range of sources, including medical literature, pharmaceutical firms, healthcare providers, national authorities, and patients themselves.⁽³⁾

Table 2: Strengths, Uses, and Limitations of Real-World Health Data Sources

Types of epidemiological Design:

Figure 2: Overview and classification framework of epidemiological study designs

Observational Vs. Experimental:

Table 3: Observational vs. Experimental Research: Methodological Differences

1.Observational Studies:

In observational investigations, the researcher notes a naturally occurring link between exposure and outcome.The researcher is only monitoring and evaluating the traits of specific groups of people in this study design. Neither medications nor surgical procedures are used as active interventions.⁽¹⁰⁾

A) Descriptive Study:

Descriptive studies focus on one or more features of a group of individuals, rather than analyzing them. They never try to provide answers or determine correlations between variables. These kinds of investigations may lead to hypotheses. Case reports, case series, and cross-sectional surveys are a few types of descriptive research.⁽¹¹⁾

Case report:

A case report is a comprehensive description of certain patients or clinical instances with distinctive disorders or complications, as well as atypical or misleading semiology, etiology, or result.⁽¹²⁾

Case Series:

A case series refers to a group of people who have the same characteristic or medical condition. They are not useful for determining whether there is a statistical correlation, but they can be used to develop hypotheses and investigate the possibilities of doing analytical or experimental research. ⁽¹²⁾

Cross‑sectional surveys:

This type of study, a cross-sectional study design, assesses a larger number of patients at once with no follow-up. A comparative group does not exist. The cause and consequences have already occurred. It can determine the prevalence of a disease or risk factor.

B) ANALYTICAL STUDY:

The goal of analytical epidemiological study designs is to comprehend the relationships between exposure and outcome. Therefore, testing hypotheses is a typical method used in analytical designs to explain why and/or how a health outcome happens. There are various kinds of them.⁽¹³⁾

Cross‑sectional analytical study:

The goal of analytical cross-sectional research is to simultaneously evaluate a dependent variable (outcome) and an independent variable (exposure) in a specific population. The main characteristic of an analytical cross-sectional study is that it collects data on exposures (risk factors or independent variables) and outcomes (illness or dependent variables) at a single point in time. The nature of cross-sectional studies is retrospective.

Cohort study:

A cohort is a collection of participants who have something in common, typically exposure to the item being studied. Until participants experience the desired effect, are lost to follow-up, or the study concludes, the cohort is tracked throughout time and compared with another cohort of unexposed people. They might be either prospective or retrospective. The two groups (exposed and unexposed) in prospective cohort studies are created prior to the onset of the desired result or illness.

Case control study:

In order to find differences in risk variables, case-control studies compare two groups, such as people with an illness (called cases) and subjects without a disease (called controls). This research is utilized to investigate an illness's etiology or risk factors, particularly when the disease is uncommon. In a case-control study, identifying controls is crucial since it can affect how the relationship between exposure and outcome is estimated. These studies are always retrospective because the results have already been obtained and are backward-directed.⁽¹³⁾

2) Interventional study:

Researchers that use interventional study designs also known as experimental study designs intervene at some point during the investigation. In an interventional investigation design, the researcher takes an active role in the process by giving an intervention to some or all participants.This is a prospective design.

Interventional study methods can be broadly classified into two categories:

1. Clinical trials

2. Community experiments.

Randomized Controlled Trials:

A randomized clinical trial may also be referred to as parallel group randomized trials or randomized controlled trials. Randomized clinical trials entail assigning patients with identical characteristics to two (or more) groups: one that receives the experimental or intervention therapy and one that receives a placebo (or standard of care). Randomization is a way to eliminate "bias" while allowing for comparability. Randomization is the "heart" of each controlled trial. It will provide the most confidence that the groups are equivalent, allowing "like can be compared with like". This is often done via computer software, manually, or by other techniques. As a result, we can measure the results and efficacy of the intervention/experimental therapy being examined without bias because patients were randomly assigned to their respective groups with equal baseline characteristics. This study design is regarded the gold standard for clinical research. This study design is not generally relevant to rare and dangerous disease processes since treating those patients with a placebo would be unethical. Randomization can be done in a variety of ways, from a simple 'flip of a coin' to using computer software and statistical approaches. To further understand randomization, consider three types: simple randomization, block randomization, and stratified randomization.⁽¹⁴⁾

Types of Randomization:

Simple randomization

Simple randomization involves assigning people to trial or intervention groups at random with a constant probability.That is, if there are two categories, A and B, the subject has a 0.5 chance of being assigned to either one. This can be done in a variety of ways, ranging from a simple 'flip of a coin' to using random tables or numbers. The benefit of utilizing this process is that it removes selection bias.

Block randomization

Block randomization groups participants with comparable features into blocks. Block randomization aims to balance the number of people assigned to each trial or intervention group.  For example, suppose there are four participants in each block, and two of them are randomly assigned to each group. As a result, there will be two subjects in one group and two in the other.

Stratified randomization

Stratified randomization involves categorizing subjects according to specific strata, which are covariates. For instance, age can serve as a covariate, allowing the population to be randomized within each age category concerning an experiment or intervention group. This approach offers the benefit of enhancing comparability between experiment and intervention groups, thereby streamlining the analysis of results.⁽¹⁵⁾

Interactive Response Technology (IRT)

Computer generated -Interactive Response Technology (IRT):

• Research sites utilize Interactive Web Response Systems (IWRS) and Interactive Voice Response Systems (IVRS) to register patients for clinical trials, assign them randomly, and oversee the distribution of study medications.

• At the core of clinical trials lies interactive response technology (IRT); this software system is essential for patient randomization and the management of the study's supply chain.

• IRT comprises two main components. Firstly, it functions as a patient management system, facilitating the inclusion of patients in the trial through screening and randomization. Secondly, the software plays a crucial role in overseeing the clinical trial supply chain. “Trials require the correct medication at the appropriate location and time, consistently.”

• IRT systems manage both the digital and physical aspects of the supply chain. According to Kole, after a drug or device is produced, it is typically given a serial number for tracking purposes. These serial numbers, together with batch IDs and expiration dates, are uploaded to the IRT.

• When a trial is initiated and begins screening or recruiting participants, the supply can then be dispatched. IRT facilitates the tracking of supplies and alerts supply managers in case of any shortages.⁽¹⁶⁾

Figure.3: Schematic of a Standardized RCT for Comparing Treatment and Control Arms with Prespecified Analysis Plans

Non-randomized Controlled Trial (nRCT):

In a non-randomized clinical trial, controls are chosen through a method that does not involve randomization. Typically, this study design follows a specific pattern, like choosing subjects and controls on particular days of the week. The predictability of this selection method introduces bias in the choice of subjects and controls, which can cast doubt on the validity of the results obtained.⁽¹⁷⁾

Figure.4 : Overview of Common Epidemiological Study Designs, Methodologies, Advantages, and Limitations.

Bias In Pharmacoepidemiological Research:

Bias refers to systemic inaccuracies in estimating pharmacological effects. It is among the most significant methodological issues in pharmacoepidemiology. In pharmacoepidemiology, biases are a serious problem because they can skew relationships between drug exposures and outcomes and provide false findings.⁽¹⁸⁾

Key biases associated with Study Population

Confounding:

Confounding occurs when a third variable associated with both exposure and result confuses the link between the two.⁽¹⁹⁾

Selection bias:

Selection bias arises when inclusion is linked to exposure and outcome, or when the study group does not reflect the intended population.⁽²⁰⁾

Information (measurement) bias:

Systematic errors in measuring exposure, outcome, or variables are referred to as information bias.

Time-related bias:

Time-related bias occurs when the exposure, result, eligibility, or follow-up times are not correctly established. In pharmacoepidemiology, these biases are particularly significant because medicine use varies throughout time.⁽²¹⁾

Table.4 A Taxonomy of Pharmacoepidemiological Biases and Their Methodological Controls

Causal inference in pharmacoepidemiology:

Pharmacoepidemiology relies heavily on causal inference because many studies use observational data rather than randomized treatment allocation to determine the impact of a medicine on a clinical outcome. The primary methodological issue in this context is that patient features, disease severity, comorbidities, contraindications, physician preference, healthcare access, and prior treatment history all have an impact on treatment choices. variances between exposed and unexposed patients may not be due to the drug's effect, but rather to individual variances.⁽²²⁾

In Modern pharmacoepidemiology uses advanced frameworks such as⁽²³⁾:

• DAGs, or directed acyclic graphs
• Target trial emulation
• Propensity score techniques
• G-methods
• The use of instrumental variables
• Sensitivity analyses

Table 5: Overview of Causal Inference Methods, Functions, and Analytical Risks